Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy

T. Hahn; Emmanuel T. Akporiaye

doi:10.3390/curroncol13040015

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Article

1 August 2006

Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy

and

Department of Microbiology and Immunology, University of Arizona, 1501 N. Campbell Avenue, P.O. Box 245049, Tucson, AZ 85724, USA

Author to whom correspondence should be addressed.

Curr. Oncol.2006, 13(4), 141-143;https://doi.org/10.3390/curroncol13040015

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Human tumours have evolved intricate mechanisms to evade the immune system, either by avoiding recognition or by inhibiting and eliminating immune cells. [...]

Keywords:

DC-based vaccine; TGFβ; immunotherapy of cancer

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Homeopathy for Cancer?

In This Issue of Current Oncology